- The trend backdrop is active with a 6-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
AVH
ASX
Week ended 07 Aug 2026
Weekly Investor Report
AVITA Medical, Inc. · Healthcare · Medical Devices
Latest close
1.54 AUD
18.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 25.4% above the Trend Line and sits at 55.1% of its 52-week range. The latest completed week returned 18.9%, after a 24.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100.
Setup score
60
out of 100
Latest Close
1.54 AUD
7 Aug 2026
1W Return
18.9%
latest completed week
4W Return
24.7%
short-term follow-through
12W Return
30.5%
quarterly tape
Trend Breadth
23.1%
12 of 52 weeks active
Volume Ratio
1.8x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 33.11% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
18.9%
Latest completed week; four-week move 24.7%.
Indicator stack
33/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Buy
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 33.11%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
51/100
34 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 25.4% above the Trend Line and sits at 55.1% of its 52-week range. The latest completed week returned 18.9%, after a 24.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2012-week average 0.14
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.20Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 24.7% over four weeks, 30.5% over 12 weeks, and 3.4% over one year. The current trend has remained active for 6 consecutive weeks.
Performance by holding period
Active trend streak6 weeks
Active weeks in one year12
Trend breadth23.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.16Latest activity-pressure read.
Pressure change4028.3%Four-week change in activity pressure.
Leadership16.73Latest relative-leadership reading.
RS change575.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 67%
Model confidence 62%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength85/100Blend of value, momentum, and quality. Underlying universe rank 16; rank 1 is best.
Value75/100Relative valuation strength. Underlying universe rank 26; rank 1 is best.
Quality73/100Profitability and accounting quality. Underlying universe rank 28; rank 1 is best.
Momentum74/100Medium-term price momentum. Underlying universe rank 27; rank 1 is best.
Growth75/100Revenue and earnings growth. Underlying universe rank 26; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 3.3x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -11.7% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 81.4% Gross profit retained from each unit of revenue.
- Operating margin
- -54.6% Operating profit retained from revenue.
- Free-cash-flow margin
- -44.9% Free cash flow generated from revenue.
- Return on invested capital
- -178.0% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 11.5% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 2/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -6.2% Net share repurchases relative to market value.
- Shareholder yield
- -6.2% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -1.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 34 relevant articles.
4 positive · 29 neutral · 1 negativePatient CapitalFresh
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-22.2%Distance below the 52-week high.
13-week volatility10.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+28.6%Week of 3 Jul.
Worst week-11.5%Week of 10 Jul.
Latest week+18.9%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains2
Flat weeks0
Modest losses10
Sharp losses6
Recent vol10.6%13-week weekly-return volatility.
Base vol10.2%52-week weekly-return volatility.
Up/down split21/30Count of positive and negative weeks in the 52-week window.
Average skew10.1% / -6.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Healthcare
4-week rank8 / 100
Group average-0.9%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD58.0%positive activity pressure
RS26.0%positive relative leadership
Four-week leaders
IndustryAU Medical Devices
4-week rank3 / 26
Group average-3.3%
Trend breadth19.2%
Trend19.2%active weekly trend signals
MD30.8%positive activity pressure
RS26.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis53/100Latest 12-week confirmation: trend 9/12, activity pressure 8/12, relative leadership 5/12.
Activity pressure 0.20; No reversal markers Next-Week ExpectancyNegative 33.11%Next-week expectancy is negative with a 33.11% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors76/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 77; Small Cap Core rank 33 Patient CapitalFreshActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal Sentiment51/100Weighted news tone is neutral across 34 relevant articles.
Can AVITA Medical (ASX:AVH) Turn RECELL Momentum Into More? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1.54 AUD | 18.9% | 1.23 AUD | 2.61 AUD | 1.16 | 16.73 | 2.4M | On |
| 31 Jul 2026 | 1.29 AUD | -1.5% | 1.21 AUD | 2.63 AUD | 0.88 | 1.26 | 690.8K | On |
| 24 Jul 2026 | 1.31 AUD | -3.7% | 1.20 AUD | 2.66 AUD | 0.90 | 4.49 | 2.3M | On |
| 17 Jul 2026 | 1.36 AUD | 10.5% | 1.20 AUD | 2.69 AUD | 0.49 | 7.34 | 2.5M | On |
| 10 Jul 2026 | 1.24 AUD | -11.5% | 1.18 AUD | 2.72 AUD | 0.03 | -3.52 | 2.0M | On |
| 3 Jul 2026 | 1.40 AUD | 28.6% | 1.18 AUD | 2.74 AUD | -0.34 | 7.51 | 765.5K | On |
| 26 Jun 2026 | 1.08 AUD | -1.4% | 1.17 AUD | 2.76 AUD | -0.55 | -16.04 | 265.0K | Off |
| 19 Jun 2026 | 1.10 AUD | 1.9% | 1.17 AUD | 2.79 AUD | -0.46 | -16.27 | 303.5K | Off |
| 12 Jun 2026 | 1.08 AUD | -6.9% | 1.17 AUD | 2.81 AUD | -0.19 | -18.22 | 792.6K | Off |
| 5 Jun 2026 | 1.16 AUD | -1.3% | 1.17 AUD | 2.84 AUD | 0.03 | -11.33 | 2.7M | On |
| 29 May 2026 | 1.18 AUD | -6.0% | 1.17 AUD | 2.86 AUD | 0.06 | -12.14 | 573.9K | On |
| 22 May 2026 | 1.25 AUD | 5.9% | 1.17 AUD | 2.88 AUD | 0.20 | -6.74 | 1.1M | On |
| 15 May 2026 | 1.18 AUD | 0.4% | 1.17 AUD | 2.89 AUD | 0.30 | -12.77 | 778.3K | On |
| 8 May 2026 | 1.18 AUD | -2.9% | 1.18 AUD | 2.91 AUD | 0.71 | -15.35 | 835.1K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.